These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 2496584)
1. [Directed chemotherapy in superficial carcinoma of the bladder conditioned by the knowledge of recurrence factors]. Oliver F; Llopis B; Vera C; Domínguez C; Vidal J; Gallego J; Jiménez JF Actas Urol Esp; 1989; 13(1):41-3. PubMed ID: 2496584 [TBL] [Abstract][Full Text] [Related]
2. [Directed chemotherapy in superficial carcinoma conditioned by the knowledge of relapse factors]. Oliver F; Llopis B; Vera C; Domínguez C; Vidal J; Gallego J; Jiménez JF Actas Urol Esp; 1988; 12(5):419-23. PubMed ID: 3218579 [No Abstract] [Full Text] [Related]
3. [Comparative study of thiotepa, adriamycin and cisplatin in the prophylaxis of recurrence of superficial bladder carcinoma in a group of 217 patients]. Llopis B; Gallego J; Boronat F; Moreno B; Mompó JA; Jiménez JF Actas Urol Esp; 1986; 10(4):225-30. PubMed ID: 3092589 [No Abstract] [Full Text] [Related]
4. [Chemoprophylaxis of superficial tumors of the bladder with thiotepa: long-term results]. Durán R; Reina GR; Hontoria JM; Merino C; Olivier C; Carballido J Actas Urol Esp; 1989; 13(1):19-23. PubMed ID: 2496583 [TBL] [Abstract][Full Text] [Related]
5. The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer. Ennis RD; Petrylak DP; Singh P; Bagiella E; O'Toole KM; Benson MC; Olsson CA J Urol; 2000 May; 163(5):1413-8. PubMed ID: 10751847 [TBL] [Abstract][Full Text] [Related]
6. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy. George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577 [TBL] [Abstract][Full Text] [Related]
7. [Intravesical instillation of doxorubicin or epirubicin for chemoprophylaxis of superficial bladder cancer--the fifth study of the Japanese Urological Cancer Research Group for Adriamycin/Farumorubicin]. Hinotsu S; Akaza H; Isaka S; Kagawa S; Koiso K; Kotake T; Machida T; Matsumura Y; Niijima T; Obata K; Ohashi Y; Ohe H; Shimazaki J; Tashiro K; Gan To Kagaku Ryoho; 2002 Jan; 29(1):73-80. PubMed ID: 11816482 [TBL] [Abstract][Full Text] [Related]
8. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma. Soga N; Arima K; Sugimura Y Int J Urol; 2008 Sep; 15(9):800-3. PubMed ID: 18651862 [TBL] [Abstract][Full Text] [Related]
9. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis. Huncharek M; McGarry R; Kupelnick B Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841 [TBL] [Abstract][Full Text] [Related]
10. [Characteristic and effective usage of adriamycin]. Horiuchi K; Akimoto M Gan To Kagaku Ryoho; 1996 Dec; 23(14):1916-9. PubMed ID: 8978797 [TBL] [Abstract][Full Text] [Related]
11. Intravesical epirubicin versus doxorubicin for superficial bladder tumors (stages pTa and pT1): a randomized prospective study. Ali-el-Dein B; el-Baz M; Aly AN; Shamaa S; Ashamallah A J Urol; 1997 Jul; 158(1):68-73; discussion 73-4. PubMed ID: 9186325 [TBL] [Abstract][Full Text] [Related]
12. Management of superficial recurrences in an irradiated bladder after combined-modality organ-preserving therapy. Weiss C; Wittlinger M; Engehausen DG; Krause FS; Ott OJ; Dunst J; Sauer R; Rödel C Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1502-6. PubMed ID: 17935905 [TBL] [Abstract][Full Text] [Related]
13. Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy. Hata M; Miyanaga N; Tokuuye K; Saida Y; Ohara K; Sugahara S; Kagei K; Igaki H; Hashimoto T; Hattori K; Shimazui T; Akaza H; Akine Y Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1371-9. PubMed ID: 16580495 [TBL] [Abstract][Full Text] [Related]
14. Intravesical therapy comparing BCG, adriamycin, and thiotepa in 200 patients with superficial bladder cancer: a randomized prospective study. Martinez-Pineiro JA; Jimenez León J; Martinez-Pineiro L; Fiter L; Mosteiro JA; Navarro J; García Matres MJ; Cárcamo P Prog Clin Biol Res; 1989; 310():237-52. PubMed ID: 2505269 [TBL] [Abstract][Full Text] [Related]